Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F WIELAND

Showing results (241-250 of 269) with videos related to

Pageof 27
Sort By:
The Journal of Infectious Diseases|January 6, 2018
Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio VaccineElizabeth B Brickley, Carolyn B Strauch, Wendy F Wieland-Alter, et al.
Pathogens & Immunity|June 27, 2024
Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2Ruth I Connor, Mrunal Sakharkar, C Garrett Rappazzo, et al.
BJU International|January 14, 2010
Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trialChristian Bolenz, Edwin Herrmann, Patrick J Bastian, et al.
World Journal of Urology|August 21, 2012
Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective seriesSabine Brookman-May, Matthias May, Vincenzo Ficarra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2025
Intestinal mucosal immune responses to novel oral poliovirus vaccine type 2 in healthy newbornsAudrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
BMJ Global Health|September 24, 2019
Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in SwedenElizabeth B Brickley, Ruth I Connor, Wendy F Wieland-Alter, et al.
The Lancet. Microbe|May 3, 2025
Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trialsAudrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
European Urology|January 2, 2008
Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective studyMaximilian Burger, Madelon N M van der Aa, Johanna M M van Oers, et al.
BJU International|June 25, 2011
Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladderMatthias May, Patrick J Bastian, Maximilian Burger, et al.
European Urology|August 16, 2011
External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladderPhilipp Nuhn, Matthias May, Maxine Sun, et al.
Pageof 27

Showing results (241-250 of 269) with videos related to

Sort By:
Pageof 27
The Journal of Infectious Diseases|January 6, 2018
Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio VaccineElizabeth B Brickley, Carolyn B Strauch, Wendy F Wieland-Alter, et al.
Pathogens & Immunity|June 27, 2024
Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2Ruth I Connor, Mrunal Sakharkar, C Garrett Rappazzo, et al.
BJU International|January 14, 2010
Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trialChristian Bolenz, Edwin Herrmann, Patrick J Bastian, et al.
World Journal of Urology|August 21, 2012
Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective seriesSabine Brookman-May, Matthias May, Vincenzo Ficarra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2025
Intestinal mucosal immune responses to novel oral poliovirus vaccine type 2 in healthy newbornsAudrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
BMJ Global Health|September 24, 2019
Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in SwedenElizabeth B Brickley, Ruth I Connor, Wendy F Wieland-Alter, et al.
The Lancet. Microbe|May 3, 2025
Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trialsAudrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
European Urology|January 2, 2008
Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective studyMaximilian Burger, Madelon N M van der Aa, Johanna M M van Oers, et al.
BJU International|June 25, 2011
Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladderMatthias May, Patrick J Bastian, Maximilian Burger, et al.
European Urology|August 16, 2011
External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladderPhilipp Nuhn, Matthias May, Maxine Sun, et al.
Pageof 27